{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:49:51Z","timestamp":1791589791147,"version":"4.3.4"},"reference-count":38,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mylan Germany GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Opioid-induced constipation (OIC) is a frequent adverse effect of opioid therapy. In contrast to other opioid-related side effects, OIC usually does not improve over time and significantly impairs the quality of life of affected patients. Despite its high prevalence, OIC remains underdiagnosed and undertreated in clinical practice, which has been demonstrated in several European countries. Healthcare data indicates that approximately 2.3 million people in Germany received potentially OIC-inducing opioids in 2023, the majority being patients with chronic non-cancer pain. Methods: An interdisciplinary board of experts in gastroenterology, pain medicine, neurology, oncology, and palliative care developed consensus-based recommendations to improve the diagnosis and management of OIC. Fifteen statements were drafted according to current national German and international guidelines and literature and subsequently discussed. Out of the fifteen statements, twelve statements remained, which achieved consensus with at least 90% agreement. Results: The consensus statements address key aspects of OIC management, including pathophysiology, patient education, diagnosis, prevention, treatment and structured follow-up. Following the statements, a practical treatment algorithm was developed to facilitate clinical implementation. Use of validated tools such as the Bowel Function Index (BFI) for diagnosis and monitoring, early initiation of laxative therapy and timely escalation to mechanism-oriented therapy with peripherally acting \u03bc-opioid receptor antagonists (PAMORAs) in cases of inadequate response have been recommended by the panel. Accordingly, treatment should follow an approach with the following steps: (1) Laxative, (2) switch to PAMORA, (3) rotation of PAMORA, and (4) combination of PAMORA with laxative. In Europe, the PAMORAs methylnaltrexone, naloxegol and naldemedine are approved for the treatment of OIC. Conclusions: This consensus paper provides both evidence-based and practice-oriented recommendations for the systematic management of OIC. By promoting patient education, early recognition, structured evaluation and stepwise treatment escalation, the presented statements and algorithm aim to improve patient outcomes and quality of life under opioid therapy including better adherence to opioid therapy.<\/jats:p>","DOI":"10.3390\/jcm15062369","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:44:41Z","timestamp":1773999881000},"page":"2369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-1470","authenticated-orcid":false,"given":"Bastian","family":"Wobbe","sequence":"first","affiliation":[{"name":"Department of Internal Medicine\u2014Oncology and Hematology, Klinikum Oldenburg AoR, 26133 Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Andresen","sequence":"additional","affiliation":[{"name":"Medizinicum Stephansplatz, 20354 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9492-4698","authenticated-orcid":false,"given":"Ralf","family":"Baron","sequence":"additional","affiliation":[{"name":"Division of Neurological Pain Research and Therapy, University Hospital Schleswig-Holstein, Campus Kiel, 24149 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Eiche","sequence":"additional","affiliation":[{"name":"Median Heinrich Mann Klinik, 36448 Bad Liebenstein, Germany"},{"name":"DGS Regional Center, 36433 Bad Salzungen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Elsner","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Gottschling","sequence":"additional","affiliation":[{"name":"Centre of Palliative Care and Pediatric Pain, Saarland University Medical Center, 66421 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ke\u00dfler","sequence":"additional","affiliation":[{"name":"Pain Medicine Section, Department of Anesthesiology, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-0265","authenticated-orcid":false,"given":"Hartmut","family":"Link","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Westpfalz-Klinikum, 677655 Kaiserslautern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8619-2433","authenticated-orcid":false,"given":"Philipp C. G.","family":"M\u00fcller-Schwefe","sequence":"additional","affiliation":[{"name":"Pain and Palliative Care Center, 73033 G\u00f6ppingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Schutter","sequence":"additional","affiliation":[{"name":"DGS Regional Center, Specialist Medical Center, Multimodal Pain Therapy at Marienhospital Marl, 45768 Marl, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Storr","sequence":"additional","affiliation":[{"name":"Center for Endoscopy, Internal Medicine Center Starnberg-Gauting, 82319 Starnberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-9492","authenticated-orcid":false,"given":"Michael A.","family":"\u00dcberall","sequence":"additional","affiliation":[{"name":"Institute of Neurological Sciences, 90411 Nuremberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-6679","authenticated-orcid":false,"given":"Stefan","family":"Wirz","sequence":"additional","affiliation":[{"name":"Department for Anesthesiology, Intensive Medicine, Pain and Palliative Medicine, Center for Pain Medicine, Weaning Center, Cura Hospital\/GFO-Clinics Bonn, 53604 Bad Honnef, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Varrassi, G., Casale, G., De Marinis, M.G., Dentali, F., Evangelista, P., Gobber, G., Lanzetta, G., Lora Aprile, P., Pace, M.C., and Portincasa, P. (2024). Improving Diagnosis and Management of Opioid-Induced Constipation (OIC) in Clinical Practice: An Italian Expert Opinion. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226689"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0043-103348","article-title":"Nebenwirkungsmanagement der Opioid-Therapie [Side effect management in opioid therapy]","volume":"55","author":"Wirz","year":"2017","journal-title":"Z. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sjpain.2015.12.005","article-title":"Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group","volume":"11","author":"Drewes","year":"2016","journal-title":"Scand. J. Pain"},{"key":"ref_4","first-page":"236","article-title":"The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports","volume":"22","author":"LoCasale","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/2050640618786145","article-title":"The patient burden of opioid-induced constipation: New insights from a large, multinational survey in five European countries","volume":"6","author":"Andresen","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_6","first-page":"160","article-title":"Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain","volume":"9","author":"Fernandes","year":"2016","journal-title":"Am. Health Drug Benefits"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/15360280903098440","article-title":"Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy","volume":"23","author":"Candrilli","year":"2009","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"ref_8","first-page":"e16201","article-title":"Efficacy and Safety of Peripherally Acting \u03bc-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients with Opioid-Induced Constipation: A Systematic Review","volume":"13","author":"Rekatsina","year":"2021","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/DDDT.S221278","article-title":"The Use of Peripheral \u03bc-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety","volume":"14","author":"Pergolizzi","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1200\/JCO.24.00381","article-title":"Naldemedine for Opioid-Induced Constipation in Patients with Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial","volume":"42","author":"Hamano","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1055\/a-1880-1928","article-title":"Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Neurogastroenterologie & Motilit\u00e4t (DGNM)\u2014April 2022\u2014AWMF-Registriernummer: 021\u2013019 [Updated S2k guideline on chronic constipation from the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology & Motility (DGNM)]","volume":"60","author":"Andresen","year":"2022","journal-title":"Z. Gastroenterol."},{"key":"ref_12","unstructured":"Leitlinienprogramm Onkologie (2019). Erweiterte S3-Leitlinie Palliativmedizin f\u00fcr Patienten Mit einer Nicht-Heilbaren Krebserkrankung [Extended S3 Guideline on Palliative Care for Patients with Incurable Cancer], Leitlinienprogramm Onkologie."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/17474124.2023.2267441","article-title":"Recommendations for the management of opioid-induced constipation\u2014How to improve usability in clinical practice","volume":"17","author":"Okdahl","year":"2023","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1188\/20.ONF.671-691","article-title":"ONS Guidelines\u2122 for Opioid-Induced and Non-Opioid-Related Cancer Constipation","volume":"47","author":"Rogers","year":"2020","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_15","unstructured":"Ueberall, M.A. (2019). DGS-PraxisLeitlinie Opioidinduzierte Obstipation (Version: 2.0 f\u00fcr Fachkreise) [DGS Practice Guideline Opioid-Induced Constipation], Deutsche Gesellschaft f\u00fcr Schmerzmedizin e.V."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/CEOR.S61602","article-title":"Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: Descriptive analysis of baseline patient-reported outcomes and retrospective chart review","volume":"6","author":"Coyne","year":"2014","journal-title":"Clin. Outcomes Res."},{"key":"ref_17","first-page":"701","article-title":"Inadequate management of opioid-induced constipation in European cancer pain patients: Results of a real-world, multicentre, observational study (\u201cE-StOIC\u201d)","volume":"32","author":"Davies","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s43472-022-00077-z","article-title":"Therapeutisches Management der chronischen Obstipation","volume":"3","author":"Pohl","year":"2022","journal-title":"Schweiz. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/gutjnl-2018-316001","article-title":"Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: Systematic review and network meta-analysis","volume":"68","author":"Luthra","year":"2019","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/147323001103900106","article-title":"The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients","volume":"39","author":"Ueberall","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1136\/bmjspcare-2020-002754","article-title":"Opioid-induced constipation: A stepwise treatment algorithm feasibility study","volume":"13","author":"Davies","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s11739-025-04091-2","article-title":"Opioid-induced constipation in internal medicine: Recognition and management pathways","volume":"20","author":"Portincasa","year":"2025","journal-title":"Intern. Emerg. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/00365520510012208","article-title":"Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire","volume":"40","author":"Marquis","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5165682","DOI":"10.1155\/2020\/5165682","article-title":"Prevalence and Risk Factors for Opioid-Induced Constipation in an Older National Veteran Cohort","volume":"2020","author":"FitzHenry","year":"2020","journal-title":"Pain Res. Manag."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.3748\/wjg.v27.i21.2795","article-title":"Potential risk factors for constipation in the community","volume":"27","author":"Werth","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_28","first-page":"149","article-title":"Managing Constipation in Adults with Cancer","volume":"8","author":"Wickham","year":"2017","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_29","unstructured":"Deutsche Schmerz (2020). S3-Leitlinie Langzeitanwendung von Opioiden bei chronischen nicht-tumorbedingten Schmerzen (LONTS): Praxiswerkzeug 9: Diagnostik und Therapie der opioidinduzierten Obstipation (OIC) [S3 Guideline on Long-Term Use of Opioids for Chronic Non-Cancer Pain: Practical Tool 9: Diagnosis and Treatment of Opioid-Induced Constipation (OIC)], Association of the Scientific Medical Societies in Germany."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/j.1552-4604.1997.tb04264.x","article-title":"Tolerance and Efficacy of Polyethylene Glycol 3350\/Electrolyte Solution Versus Lactulose in Relieving Opiate Induced Constipation: A Double-Blinded Placebo-Controlled Trial","volume":"37","author":"Freedman","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"ref_31","first-page":"131","article-title":"Laxative management in ambulatory cancer patients on opioid therapy: A prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose","volume":"21","author":"Wirz","year":"2012","journal-title":"Eur. J. Cancer Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2982.2003.00426.x","article-title":"Abdominal distension after colonic lactulose fermentation recorded by a new extensometer","volume":"15","author":"Basilisco","year":"2003","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cordero-P\u00e9rez, F.J., P\u00e9rez-Baena, M.J., Pina-Ruviralta, N., Fern\u00e1ndez-Testa, A., and Holgado-Madruga, M. (2026). Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence. Healthcare, 14.","DOI":"10.3390\/healthcare14040457"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5649\/jjphcs.47.411","article-title":"Effect of the Opioid Administration Period before the Initiation of Naldemedine Administration on the Prevalence of Diarrhea","volume":"47","author":"Shirata","year":"2021","journal-title":"Iryo Yakugaku (Jpn. J. Pharm. Health Care Sci.)"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/JPR.S220859","article-title":"Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions","volume":"13","author":"Gudin","year":"2020","journal-title":"J. Pain Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2014.01.005","article-title":"A Prospective Study to Investigate Contributory Factors That Lead to Constipation in Palliative Care Patients","volume":"47","author":"Clark","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e230310","DOI":"10.1001\/jamanetworkopen.2023.0310","article-title":"Effects of Electroacupuncture for Opioid-Induced Constipation in Patients with Cancer in China: A Randomized Clinical Trial","volume":"6","author":"Wang","year":"2023","journal-title":"JAMA Netw. Open"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:10:33Z","timestamp":1774001433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062369"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062369","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}